|
 |
Managing fraud risk as a life
science company
Whether it takes the form of counterfeit
products slipping into the supply chain or involves employees of a company engaging
in unlawful pricing activities, fraud costs life science companies billions of
dollars annually. Page 4
Antihypertensive treatments on the rise
There are many approaches to the treatment of hypertension and new and improved
approaches continue to emerge. There are currently around 316 clinical trials
of antihypertensive treatments under way with various mechanisms of action.Page
13
Conducting clinical trials
in Brazil
The dynamics of patient recruitment for
clinical trials are changing, with companies keen to extend beyond the traditional
core markets and make use of emerging markets, such as Brazil, which is becoming
an increasingly popular site for trials. However, companies should familiarize
themselves with local regulatory processes and bureaucratic hurdles to minimize
delays in drug development. Page 16 |
